Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 130, Issue 3, 297-301
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matthews, S.
Right arrow Articles by Parrott, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matthews, S.
Right arrow Articles by Parrott, R.

Articles

Centrally administered vasopressin modifies stress hormone (cortisol, prolactin) secretion in sheep under basal conditions, during restraint and following intravenous corticotrophin-releasing hormone

SG Matthews and RF Parrott

AFRC Institute of Animal Physiology and Genetics Research, Cambridge Research Station, UK.

The effects of central (lateral ventricle) injections of vasopressin (2.5, 25 or 250 ng) on cortisol and prolactin release were investigated in castrated male sheep (N = 6) under basal (non-stress) conditions, during 120min of physical restraint and following peripheral injection of ovine corticotrophin-releasing hormone (oCRH). Cortisol and prolactin concentrations in non-stressed sheep were raised significantly (p < 0.05) in the 120 min following administration of 250 ng of vasopressin. The prolactin response to restraint stress was decreased (p < 0.05) in the 30-min period following central injection of 250 ng of vasopressin. The stimulatory effect of oCRH on cortisol release was enhanced (p < 0.05) by vasopressin (25 and 250 ng), whereas prolactin levels decreased (p < 0.02) in the 30-min period following injection of the highest dose of vasopressin. None of the central doses of vasopressin significantly altered plasma levels of this hormone, although vasopressin secretion was increased during restraint.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Korbonits, G. Kaltsas, L. A. Perry, P. Putignano, A. B. Grossman, G. M. Besser, and P. J. Trainer
The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2489 - 2495.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.